Abiomed to Present at Upcoming Investor Conferences

Rhea-AI Summary

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) announced that Michael R. Minogue, Chairman, President and CEO, will hold a fireside chat at the Stephens Annual Investment Conference on December 1, 2021, at 3:00pm ET, and at the Piper Sandler Virtual Healthcare Conference on December 2, 2021, at 11:00am ET. Abiomed is known for its heart support technologies, improving blood flow and performing heart pumping. For more information, visit www.abiomed.com.

DANVERS, Mass.--(BUSINESS WIRE)-- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will hold a fireside chat at the Stephens Annual Investment Conference 2021 on Wednesday, December 1, 2021, at 3:00pm ET and at the Piper Sandler Virtual Healthcare Conference on December 2, 2021, at 11:00am ET.

ABOUT ABIOMED
Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. For additional information, please visit: www.abiomed.com.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements, including with respect to Abiomed's development of existing and new products, the Company's commercial growth, future business opportunities and pending regulatory approvals. The Company's actual results may differ materially from those anticipated in these forward-looking statements due to a number of factors, including uncertainties related to the scope, extent and duration of the impact of the COVID-19 pandemic, development, testing and related regulatory approvals, including the possibility of future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological changes, governmental requirements, litigation, future capital requirements and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent filings with the SEC. Readers of this press release are advised not to evaluate forward-looking statements, which reflect information available only as of the date of this release, as reliable information. The Company is under no obligation to release updates to these forward-looking statements to reflect events or circumstances occurring after the date of the release or as a result of the impact of unforeseen events.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211118005263/en/

Todd Trapp

Vice President and Chief Financial Officer

978-646-1680

ttrapp@abiomed.com

Source: Abiomed, Inc.

FAQ

What events is Abiomed participating in December 2021?

Abiomed will be at the Stephens Annual Investment Conference on December 1, 2021, and the Piper Sandler Virtual Healthcare Conference on December 2, 2021.

Who is the CEO of Abiomed?

Michael R. Minogue is the Chairman, President, and CEO of Abiomed.

What is the focus of Abiomed's technologies?

Abiomed focuses on breakthrough heart support technologies that improve blood flow and assist in heart pumping.

How can I learn more about Abiomed?

For more information about Abiomed, visit their website at www.abiomed.com.

What stock symbol represents Abiomed?

Abiomed is represented by the stock symbol ABMD on NASDAQ.